Yonsei University Health System
Seoul 3722
3 studies enrolling now · 11 studies all time
What they study most
Arthritis, Rheumatoid, CRT-D Cardiac Resynchronization Therapy Defibrillator, Diffuse Large B Cell Lymphoma, Endometrial Cancer, Gastric Cancer, Heart Failure, Implantable Cardioverter Defibrillators, Locally Advanced Solid Tumor, Low-grade Serous Ovarian Cancer, Metastatic Pancreatic Adenocarcinoma, Metastatic Solid Tumor, Recurrent Endometrial Cancer
Studies at this site
- Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers — Recruiting now
- A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma — Recruiting now
- A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) — Recruiting now
- Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma — Running, not enrolling
- A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed
- Derazantinib and Atezolizumab in Patients With Urothelial Cancer — Completed
- MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
- LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices — Completed
- Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) — Completed
- Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) — Completed
- Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed